Skip Navigation


PEDS Advance Access originally published online on July 31, 2006
Protein Engineering Design and Selection 2006 19(10):453-460; doi:10.1093/protein/gzl030
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/10/453    most recent
gzl030v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Venisnik, K. M.
Right arrow Articles by Wu, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venisnik, K. M.
Right arrow Articles by Wu, A. M.
Related Collections
Right arrow 2006
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Bifunctional antibody-Renilla luciferase fusion protein for in vivo optical detection of tumors

Katy M. Venisnik1, Tove Olafsen1, Andreas M. Loening2,3, Meera Iyer1,2, Sanjiv S. Gambhir2,3 and Anna M. Wu1,4

1 Crump Institute for Molecular Imaging, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza Los Angeles, CA 90095 2 Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program CA 94305, USA 3 Department of Bioengineering, Stanford University, 300 Pasteur Drive, Stanford CA 94305, USA

4To whom correspondence should be addressed. E-mail: awu{at}mednet.ucla.edu

An anti-carcinoembryonic antigen (CEA) antibody fragment, the anti-CEA diabody, was fused to the bioluminescence enzyme Renilla luciferase (RLuc) to generate a novel optical imaging probe. Native RLuc or one of two stabilized variants (RLucC124A, RLuc8) was used as the bioluminescent moiety. A bioluminescence ELISA showed that diabody-luciferase could simultaneously bind to CEA and emit light. In vivo optical imaging of tumor-bearing mice demonstrated specific targeting of diabody-RLuc8 to CEA-positive xenografts, with a tumor:background ratio of 6.0 ± 0.8 at 6 h after intravenous injection, compared with antigen-negative tumors at 1.0 ± 0.1 (P = 0.05). Targeting and distribution was also evaluated by microPET imaging using 124I-diabody-RLuc8 and confirmed that the optical signal was due to antibody-mediated localization of luciferase. Renilla luciferase, fused to biospecific sequences such as engineered antibodies, can be administered systemically to provide a novel, sensitive method for optical imaging based on expression of cell surface receptors in living organisms.

Keywords: bioluminescence/carcinoembryonic antigen/engineered antibodies/nude mouse xenograft models/Renilla luciferase

Received January 11, 2006; revised May 3, 2006; accepted June 14, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
R. H. Brown, C. G. Irvin, G. B. Allen III, S. D. Shapiro, W. J. Martin, M. R. J. Kolb, D. M. Hyde, G. F. Nieman, D. D. Cody, M. Ishii, et al.
An Official ATS Conference Proceedings: Advances in Small-Animal Imaging Application to Lung Pathophysiology
Proceedings of the ATS, July 15, 2008; 5(5): 591 - 600.
[Full Text] [PDF]


Home page
JNMHome page
E. J. Akins and P. Dubey
Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 180S - 195S.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.